NDC properties for NDC 9 51759-523
NDC item 51759052321
| NDC 9 | 51759-523 |
|---|---|
| NDC 10 | 51759-523-21 |
| NDC Item | 51759052321 |
| packaging | 1 KIT in 1 CARTON (51759-523-21) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE (51759-634-31) * .4 mL in 1 POUCH (65517-0002-1) |
| BLA | BLA761299 |
| FDA SPL set id | 800492 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-07-31 |
| Marketing status | active |
NDC item 51759063431
| NDC 9 | 51759-634 |
|---|---|
| NDC 10 | 51759-634-31 |
| NDC Item | 51759063431 |
| packaging | 0.8 mL in 1 SYRINGE |
| FDA SPL set id | 800492 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |